
Opinion|Videos|July 1, 2024
Overview of the Port Delivery System with Ranibizumab
Author(s)Margaret A. Chang, MD, MS
Margaret Chang, MD, examines the difficulties of frequent anti-VEGF injections and outlines the key aspects of the port delivery system (PDS) for ranibizumab administration.
Advertisement
- Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections?
- Can you provide an overview of the port delivery system with ranibizumab?
- How does the device function?
- How is the device implanted?
- How is the device refilled?
- What are the benefits of using the PDS with ranibizumab, and which patients are ideal candidates for this delivery method?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Study identifies 6 key genes linking air pollution to dry eye disease
2
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
3
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
4
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
5

















































.png)


